Sean Salmon - Dec 13, 2022 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & President Cardiovascular
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Stock symbol
MDT
Transactions as of
Dec 13, 2022
Transactions value $
-$418,709
Form type
4
Date filed
12/16/2022, 06:28 AM
Previous filing
Dec 9, 2022
Next filing
Aug 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Options Exercise $100K +1.81K +5.01% $55.32 37.9K Dec 13, 2022 Direct
transaction MDT Ordinary Shares Options Exercise $820K +14.8K +39.11% $55.32 52.7K Dec 13, 2022 Direct
transaction MDT Ordinary Shares Sale -$1.34M -16.6K -31.55% $80.50 36.1K Dec 13, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -1.81K -100% $0.00* 0 Dec 13, 2022 Ordinary Shares 1.81K $55.32 Direct
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -14.8K -100% $0.00* 0 Dec 13, 2022 Ordinary Shares 14.8K $55.32 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.48 to $80.545 inclusive. The reporting person undertakes to provide Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.